Patient Identification

M2GEN and Discovery Life Sciences Enter into Agreement to Leverage M2GEN’s New Oncology-Focused Bioinformatics Support Services | PR Newswire | 9/25/2020

… significantly contributed to building M2GEN’s ORIEN AVATAR® database which has recently been launched to the global pharma, biopharma and molecular and companion diagnostic industry to enhance oncology research, improve protocol design for and support patient identification and enrollment to clinical trials, thus, accelerating the discovery and development of new diagnostics, medicines and targeted therapies for cancer patients. “M2GEN’s best in class bioinformatics services, combined with the ability to annotate data …

Thynk Health Solution Empowers MercyOne Des Moines to Grow Lung Screening Program | PR Newswire | 9/24/2020

… risk of lung cancer. This data is reported in a simple and actionable interface that allows the MercyOne team to quickly act on findings with automated communications and outreach to patients and providers. Advanced patient identification and automation have translated into tremendous growth in the MercyOne Lung Cancer Screening, Incidental Pulmonary Nodule, and Lung Cancer Program with a 76.2 percent increase in the number of new patients undergoing screening from …

Follow Patient Identification:    

Medical Affairs Executive Director - North & South Dakota/Minnesota/Nebraska/Iowa (Ecosystem) : Fargo | 9/22/2020

… of our medicines, services, technology, talents) along the healthcare continuum. Prioritize relationships with key access decision-makers in healthcare systems, managed care organizations, payers, and government programs to optimize appropriate coverage policy, pathway inclusion, patient identification algorithms; further developing medically driven mitigation strategies to remove barriers impacting patients access to Genentech products Define the strategic near and long-term medical vision and direction for the healthcare region in order to …

Implementation of a Postfracture Care Program in a Private Hospital in Colombia | 9/18/2020

… increasing life expectancy in Colombia (74 years in 2019 [ 7 ]), the direct relation between age and fragility fractures, and the rate of elderly patients admitted in the emergency room (23%). This program focuses on patient identification , education, treatment, and outpatient follow-up, with the goal of preventing new fractures. It was implemented following the guidelines of the “Capture the Fracture”, an initiative developed by the International Osteoporosis Foundation through its …

A Virtual Feast: A Preview of Bio-IT World Conference & Expo 2020 | PRWeb | 9/16/2020

… diseases. This creates a significant burden, not just for patients, but for healthcare systems. Tom Defay, Alexion, will share examples of collaboration with researchers and hospital systems to develop novel approaches for rare disease patient identification using tools like genomics, machine learning, and NLP. Thursday, October 8 Biomedical research over the last decade has become increasingly complex, and different disciplinary experts are needed to solve challenging scientific questions. No longer …

Zebra delivers the tools you need for positive patient ID | 9/16/2020

… goal is the same – it’s all about fast access to data. Healthcare is no exception to that. Even before 2020 brought an entirely new host of challenges, it was already the case that positive patient identification (PPID) was a major area of focus for healthcare teams worldwide. From admission to discharge, it’s always been vitally important to accurately access and confirm essential patient information throughout the entire care journey. That …

Radiologic Technologist II - USA-CA-Riverside | 9/14/2020

… s) of interest.Essential Functions:- Operates various x-ray control consoles, portable units, tube assemblies, lock systems, collimators, filters and tables in order to perform diagnostic radiographic procedures and examinations.- Ensures that correct and required patient identification and left or right marker appears on all films.- Centers area of interest to film and tube.- Utilizes appropriate use of phototiming, milliamperes (MA), kilovoltage (KVP), seconds, distance, collimation, intensifying screens, film speed and …

The Effects of Weed - How Five Different Strains of Medical Marijuana Affect the Mind and Body | 9/14/2020

… prescribe legal levels of cannabis sativa to patients according to diagnoses, observations, as well as from the advice of a family physician, with substantiating records provided to look at the reason for a prescription. Patient identification, the diagnoses or conditions that support the utilization of marijuana along with the amount and strength prescribed are maintained record to exhibit strict adherence towards the legislation in position.1. Crohns Disease - Various studies …

Nuclear Medicine Technologist | 9/12/2020

… floater Facility within the San Fernando Valley in California . Job Purpose: Conducts diagnostic and evaluative studies and provides therapies by utilizing the nuclear properties of radioactive and stable isotopes. Duties: Registers patients by confirming patient identification ; reviewing consultation requests; checking for special instructions; consulting with the radiologist; entering anticipated services to patient log. Comforts patients and their families by answering questions; responding to requests; elaborates on pending/current procedure and …

Thales Patient Identification in Healthcare Establishments | 9/11/2020

Thales Patient Identification in Healthcare Establishments Sept. 11, 2020 The multiple locations used for patient identification in healthcare establishments (admissions office, emergency services, care units, consultation services), the number and type of staff involved (administrative personnel, carers, etc.) the use of different software applications lead to risks of errors in patient identification: Duplication’s: Information system contains several identities for one and the same physical person; Collisions: Two physical persons are …

COVID-19 Impact on Global Healthcare Barcode Scanners Market Insights, Forecast to 2026 | 9/11/2020

… by Type and by Application for the period 2015-2026. Segment by Type, the Healthcare Barcode Scanners market is segmented into 1D 2D Others Segment by Application, the Healthcare Barcode Scanners market is segmented into Patient Identification Bedside Medication Verification Lab Specimen Track And Trace Others Regional and Country-level Analysis The Healthcare Barcode Scanners market is analysed and market size information is provided by regions (countries). The key regions covered …

Lyniate and 4medica Announce Referral Partnership to Enhance Data Integrity and Interoperability | PRWeb | 9/10/2020

Lyniate and 4medica Announce Referral Partnership to Enhance Data Integrity and Interoperability Share Article Leaders in Healthcare Data Interoperability, Patient Identification and Matching Establish Agreement to Help Provider Organizations Eliminate Duplicate Patient Files, Facilitate Seamless Data Integration 4medica Master Patient Index as-a-Service™ “Historically, duplicate patient files have created a significant burden across the entire healthcare continuum,” said Drew Ivan, Chief Product and Strategy Officer at Lyniate. BOSTON and …

Prognos Health Names New VP of Product Strategy and VP of Sales for Payer Market | PR Newswire | 9/10/2020

… source of clinical diagnostics information in 50 disease areas, with nearly billions of medical records for hundreds of millions of patients. Prognos has over 1,000 extensive proprietary and learning clinical algorithms to enable earlier patient identification for enhanced treatment decision-making, risk management and quality improvement. The company’s investors include Safeguard Scientifics, Inc., Merck Global Health Innovation Fund, Cigna, GIS Strategic Ventures, Hikma Ventures, Hermed Capital, and Maywic Select Investments …

CHIME Advises ONC to Help Lift National Patient Identifier Ban | EHR Intelligence | 9/9/2020

… 09, 2020 - CHIME has issued a letter in support of a national patient identifier (NPI) to the Office of the National Coordinator for Health Information Technology (ONC), on the need for accurate patient matching, patient identification , and data standards. This comes on the heels of the US House of Representatives’ approval to the bipartisan Foster-Kelly Amendment, removing Section 1510 of the Labor-HHS bill that prohibits the use of …

Arizona imaging provider’s EHR hit by ransomware exposing info of 244,800 patients | Becker’s Hospital Review | 9/8/2020

… were accessed by an unknown attacker from May 15-17. Some data was exfiltrated from its systems during that period, Assured stated. Patient information affected by the security incident includes names, addresses, dates of birth, patient identification numbers and medical histories. After discovering the ransomware attack, Assured notified HHS and other government regulators and is reviewing its privacy policies to implement more safeguards. More articles on cybersecurity …

Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer | PR Newswire | 9/5/2020

… said Jeff Albers , Chief Executive Officer of Blueprint Medicines. “We are working with our partner Genentech to rapidly bring GAVRETO to healthcare providers and patients in the U.S., applying our complementary capabilities to support patient identification and access to treatment. Ultimately, we aim to accelerate the identification of patients with RET fusion-positive non-small cell lung cancer and enable them to rapidly access treatment with GAVRETO.” GAVRETO was granted …

Blueprint Medicines Announces FDA Approval of GAVRETO(TM) (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer | 9/5/2020

… said Jeff Albers , Chief Executive Officer of Blueprint Medicines. “We are working with our partner Genentech to rapidly bring GAVRETO to healthcare providers and patients in the U.S., applying our complementary capabilities to support patient identification and access to treatment. Ultimately, we aim to accelerate the identification of patients with RET fusion-positive non-small cell lung cancer and enable them to rapidly access treatment with GAVRETO.” GAVRETO was granted …

Blueprint, Roche take on Lilly with FDA approval for RET cancer drug Gavreto - FiercePharma | 9/5/2020

… priority” for the company’s marketing team, which employs more than 40 sales reps, Blueprint’s chief commercial officer, Christy Rossi, said ahead of the approval. Another part of the Blueprint commercial group is focused on patient identification , as testing is important for a targeted therapy such as Gavreto, she added. Virtual Event DEVELOP A UNIFIED SCIENTIFIC VOICE The virtual Medical Affairs Strategic Summit (MASS) provides a platform for the greater medical …

HIMSSCast: The US needs a patient identification strategy yesterday | Healthcare IT News | 9/4/2020

Government & Policy HIMSSCast: The US needs a patient identification strategy yesterday Joined by Tom Leary and David Gray of HIMSS Government Relations, the team recaps the recent HHS working session. September 04, 2020 01:10 PM Earlier this week, an HHS working session met to discuss a long-simmering topic in American health policy: the need for a universal patient-identification strategy. In this episode of HIMSSCast, host Jonah Comstock and …

Oncocyte and the Guardian Research Network® Announce Strategic Alliance NYSE:OCX | Globe Newswire | 9/3/2020

… is a consortium of over 150 hospitals and clinics focusing on executing clinical trials for oncology. The network has relationships with esteemed hospitals across the U.S. and works to facilitate clinical trial activities, including patient identification and study design optimization. Oncocyte’s molecular tools and diagnostic assays, specifically DetermaIO, its multivariate gene expression test which can identify immune checkpoint inhibitor responders, will allow GRN to optimize enrollment and support the development …

Coalition Calls On Congress to Lift National Patient Identifier Ban | EHR Intelligence | 9/1/2020

… say. While patient safety is a significant concern , a lack of accurate patient matching also presents financial issues for health systems. According to The Ponemon Institute, 35 percent of denied claims come from inaccurate patient identification or incomplete patient information, costing the average provider $1.2 million per year. The group said Congress must repeal a section of the law that prevents the Department of Health and Human Services (HHS) from …

Accurate patient matching is even more vital amidst the COVID-19 crisis, say industry groups | Healthcare IT News | 8/31/2020

… COVID-19 vaccine, too, large-scale immunization programs will depend on accurate patient information – including determining who has had the disease, who has been vaccinated and patient outcomes. “Not having a true approach to patient identification “ is exacerbating existing public health issues associated with the crisis, said Leary. Leary, along with Premier Healthcare Alliance senior director of federal affairs Meryl Bloomrosen, spoke on behalf of Patient ID Now, a multi …

Patient Access Supervisor - Phoenix, AZ - UnitedHealth Group - Phoenix, AZ | 8/28/2020

… seeking an energetic candidate for our Patient Registration Department at The University of Arizona Cancer Center @ Dignity Health St. Joseph’s Hospital and Medical Center. The perfect candidate will facilitate the patient admission flow, including patient identification , accurate demographics, insurance authorization, notification and verification of insurance e - benefits in order to obtain accurate and prompt reimbursement. Additional duties include providing information and answering questions about payment assistance collecting co - payments, patient …

Unique Patient Identifiers Could Help Streamline Nation’s Health Information Technology Infrastructure | 8/26/2020

The Association for Clinical Oncology (ASCO) recently submitted comments to the Office of the National Coordinator for Health Information Technology (ONC) in response to its request for comments on improving patient identification and matching in the nation’s health information technology infrastructure. In its comments, ASCO urges ONC to work across federal agencies and the private sector to develop a unique patient identifier (UPI). ASCO recommends that priority be given to …

Medical Identity Theft Protection can be Achieved with Accurate Patient Identification | 8/25/2020

… is medical identity theft. If they ensure medical identity theft protection, they can mitigate significant costs. RightPatient ensures medical identity theft protection It was previously stated that medical identity theft is closely tied to patient identification. If a caregiver can accurately identify the patient at the point of registration, it can prevent medical identity theft . That’s exactly what RightPatient does. It is a photo-based, touchless biometric patient identification used …

Medicaid

CHIME Advises ONC to Help Lift National Patient Identifier Ban | EHR Intelligence | 9/9/2020

… NPI) to the Office of the National Coordinator for Health Information Technology (ONC), on the need for accurate patient matching, patient identification, and data standards. This comes on the heels of the US House of … we recommend ONC work collaboratively with the Centers for Medicare & Medicaid Services (CMS) to examine instances of duplicate records and overutilization as a result of identification issues with the dual eligible (Medicare and Medicaid) populations …

Medicare

CHIME Advises ONC to Help Lift National Patient Identifier Ban | EHR Intelligence | 9/9/2020

… NPI) to the Office of the National Coordinator for Health Information Technology (ONC), on the need for accurate patient matching, patient identification, and data standards. This comes on the heels of the US House of … particular, we recommend ONC work collaboratively with the Centers for Medicare & Medicaid Services (CMS) to examine instances of duplicate records and overutilization as a result of identification issues with the dual eligible (Medicare and Medicaid …

Food and Drug Administration

Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer | PR Newswire | 9/5/2020

… BPMC ), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the U.S. Food and Drug Administration (FDA) has approved GAVRETO™ (pralsetinib) for the treatment of adult patients … patients in the U.S., applying our complementary capabilities to support patient identification and access to treatment. Ultimately, we aim to accelerate the identification of patients with RET fusion-positive non-small cell lung cancer and …

HIMSS

HIMSSCast: The US needs a patient identification strategy yesterday | Healthcare IT News | 9/4/2020

Government & Policy HIMSSCast: The US needs a patient identification strategy yesterday Joined by Tom Leary and David Gray of HIMSS Government Relations, the team recaps the recent HHS working session. September 04, 2020 01:10 PM Earlier this week, an HHS working session met to discuss a long-simmering topic in American health policy: the need for a universal patient-identification strategy. In this episode of HIMSSCast, host Jonah Comstock and …

Health Information Management

Coalition Calls On Congress to Lift National Patient Identifier Ban | EHR Intelligence | 9/1/2020

… Patient Identifier (NPI) System In addition to Premier, Patient ID Now consists of, the American College of Surgeons, the American Health Information Management Association (AHIMA), the College of Healthcare Information Management Executives (CHIME), Healthcare Information … Ponemon Institute, 35 percent of denied claims come from inaccurate patient identification or incomplete patient information, costing the average provider $1.2 million per year. The group said Congress must repeal a section of the law …

Population Health

RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease | Globe Newswire | 8/21/2020

… and cardiovascular disease,” said Barbara Murphy, MD, Chair of the Samuel Bronfman Department of Medicine, Dean for Clinical Integration and Population Health Management at the Icahn School of Medicine at Mount Sinai, and board member … early identification of previously hidden high-risk patient groups Accelerate patient identification and recruitment for clinical trials Complement commercialization efforts with outcomes from KidneyIntelX results “This collaborative approach reflects the shared vision of AstraZeneca and …

Health Management

RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease | Globe Newswire | 8/21/2020

… cardiovascular disease,” said Barbara Murphy, MD, Chair of the Samuel Bronfman Department of Medicine, Dean for Clinical Integration and Population Health Management at the Icahn School of Medicine at Mount Sinai, and board member of … early identification of previously hidden high-risk patient groups Accelerate patient identification and recruitment for clinical trials Complement commercialization efforts with outcomes from KidneyIntelX results “This collaborative approach reflects the shared vision of AstraZeneca and …

Telehealth

Practical tech, innovation investment in the coming months: 2 focal areas for Banner Health | Becker’s Hospital Review | 7/1/2020

Deanna Wise, senior vice president and CIO of Phoenix-based Banner Health, sees continuing to focus on telehealth and home monitoring technology as well as delivering information about vaccinations faster as the important technologies she’ll … 2D barcoding to streamline immunization practices since 2011, and accurate patient identification, product identification and automatic data capture for speedy vaccinations will make the process successful. “Banner Health’s focus to implement speedy vaccination stations will …

CDC

Practical tech, innovation investment in the coming months: 2 focal areas for Banner Health | Becker’s Hospital Review | 7/1/2020

CDC and its immunization partners have explored the potential of 2D barcoding to streamline immunization practices since 2011, and accurate patient identification, product identification and automatic data capture for speedy vaccinations will make the process successful. “Banner Health’s focus to implement speedy vaccination stations will be on the availability of the right technology and vaccine products, while adhering to federal and state laws and best practices,” she said. “Alongside the …

COVID-19

‘Will You Help Save My Brother?’: The Scramble to Find Covid-19 Plasma Donors | MSN | 4/29/2020

Will You Help Save My Brother?’: The Scramble to Find Covid-19 Plasma Donors The New York Times 1 hr ago Audra D. S. Burch and Amy Harmon © Saul Martinez for The New York Times … for three patients, he asked, could she list his relative’s patient identification on her form as well? “It seems like we have fairy status or something,” said Ms. Chamberlin, who ended up flying from Richmond …

Digital Health

In a COVID-19 hotspot, a physicians group deploys a free triage and telehealth tool | Healthcare IT News | 3/26/2020

… and virtual-triaging capabilities to doctors, and track and trace high-risk populations. Before and after Tamra Ruymann, Chief of Digital Health at Physicians of Southwest Washington, first explains how her caregiver colleagues are treating … confirmed and highly likely cases, as well as high-risk patient identification. “Using this information, our care management team is working to implement remote patient-monitoring tools for the confirmed cases that are recovering in …

Precision Medicine

Caris Life Sciences and Ambry Genetics Partner to Advance Cancer Care | PR Newswire | 12/4/2019

… ALISO VIEJO, Calif. , Dec. 4, Caris Life Sciences ® , a leading innovator in molecular science focused on fulfilling the promise of precision medicine, and Ambry Genetics (Ambry), a leading clinical genetic testing company, today announced that … traditional physician outreach model to a real-time approach where patient identification is completed at the lab and the physician is informed so that the patient can be enrolled days earlier, and remain in the …

Electronic Health Records

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

… to-end patient enrollment technology and services in oncology clinical trials for patients treated at community practices. These services include patient identification/engagement, pre-screening, JIT site activation, and real-world data services. Massive Bio … proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland. Clinerion’s …

Patient Recruitment

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

… offers Massive Bio access to oncology patient insights for site outreach and identification of cohorts for trial site selection and patient recruitment. Clinerion’s Patient Network Explorer queries anonymized patient data from its international network of … trials for patients treated at community practices. These services include patient identification/engagement, pre-screening, JIT site activation, and real-world data services. Massive Bio structures medical records, NGS results and clinical trials with its …

Clinical Research

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

… to-end patient enrollment technology and services in oncology clinical trials for patients treated at community practices. These services include patient identification/engagement, pre-screening, JIT site activation, and real-world data services. Massive Bio … to support cancer patients in bringing them access to international clinical research and accelerate the development of next generation medical interventions,” says Ian Rentsch, CEO of Clinerion. “This partnership gives us yet another way to …

Real World Evidence

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

… screening and inclusion in trials, speeding up patient recruitment. Massive Bio provides end-to-end patient enrollment technology and services in oncology clinical trials for patients treated at community practices. These services include patient identification/engagement, pre-screening, JIT site activation, and real-world data services. Massive Bio structures medical records, NGS results and clinical trials with its proprietary ontologies and Natural Language Processing (NLP) technology. Massive Bio has also …

National Cancer Institute

University of Minnesota Joins Precision Oncology Alliance Led by Caris Life Sciences | PR Newswire | 11/26/2019

… reducing the burden of cancer can be directly attributed to research advances. Founded in 1991, the cancer center became a National Cancer Institute (NCI)-designated comprehensive cancer center in 1998, one of only 51 institutions … traditional physician outreach model to a real-time approach where patient identification is completed at the lab and the physician is informed so that the patient can be enrolled days earlier, and remain in the …

Patient Care Plans

(USA-VT-Rutland) Nursing Unit Assistant (Casual/Per Diem) | 11/24/2019

patient identification is missing; Assist with the dining program as assigned. Assists with feeding patients in accordance with the Feeding Assistant Program once successfully completed. Provides additional nourishment and hydration per patient care plans; Records patient’s oral intake and output; Uses Point Click Care (PCC – ADL POC) according to the Business Processes, if applicable; Answers call light or bell promptly, delivers messages, cleans areas of spillage or accidents; Uses Standard …

Enterprise Master Patient Index

NextGate Recognized by Leading Analyst Firm Gartner as ‘Notable Next-Generation EMPI Vendor’ | PR Newswire | 11/22/2019

PASADENA, Calif. , Nov. 22, NextGate , the global leader in healthcare enterprise identification, announced today it has been recognized as a ‘Notable Next-Generation Enterprise Master Patient Index (EMPI) Vendor’ in a new report from Gartner, Inc. The report, entitled, Identity Biometrics and Next-Generation EMPIs Combine to Address Duplicate Medical Records and HIE Challenges , offers a proactive, positive patient identification strategy for healthcare provider CIOs seeking EHR and care delivery …

Medical Errors

NextGate Recognized by Leading Analyst Firm Gartner as ‘Notable Next-Generation EMPI Vendor’ | PR Newswire | 11/22/2019

… entitled, Identity Biometrics and Next-Generation EMPIs Combine to Address Duplicate Medical Records and HIE Challenges , offers a proactive, positive patient identification strategy for healthcare provider CIOs seeking EHR and care delivery IT optimization. “EMPIs … vital importance our patient identity management technology brings to reducing medical errors and eliminating needless costs and inefficiencies that result from duplicate medical records.” Disclaimer: Gartner does not endorse any vendor, product or service depicted …

Patient Registration

Senior Patient Care Coordinator - Phoenix, AZ - UnitedHealth Group - Phoenix, AZ | 11/21/2019

Patient Registration Department at The University of Arizona Cancer Center @ Dignity Health St. Joseph’s Hospital and Medical Center. The perfect candidate will facilitate the patient admission flow, including patient identification, accurate demographics, insurance authorization, notification and verification of insurance e - benefits in order to obtain accurate and prompt reimbursement. Additional duties include providing information and answering questions about payment assistance collecting co - payments, patient liabilities, compliance with HIPAA, and entering …

HIPAA

Senior Patient Care Coordinator - Phoenix, AZ - UnitedHealth Group - Phoenix, AZ | 11/21/2019

… patient identification, accurate demographics, insurance authorization, notification and verification of insurance e - benefits in order to obtain accurate and prompt reimbursement. Additional duties include providing information and answering questions about payment assistance collecting co - payments, patient liabilities, compliance with HIPAA, and entering all necessary information into the hospital computer system. As a Senior Patient Care Coordinator , we are often the first point of contact for our patients and their families …

EMR

Medical Records Technician | 11/20/2019

A reputable healthcare company in the downtown Louisville area is looking to add a EMR Tech to their team. PAY: $15/hour HOURS: Monday through Friday (8:00 - 5:00) Job Description: The EMR Technician is responsible for prepping, scanning and indexing of documents into the EMR to ensure document type accuracy and positive patient identification. Triages all Ambulatory documents and route faxes using established workflow procedures. Scans and routes results via …

Electronic Medical Record

(USA-OH-CINCINNATI) Scheduler - Oncology/Hematology | 11/19/2019

patient identification and maximum reimbursement for all billable clinical services rendered. The Scheduler may perform the following duties: Manages daily patient and physician scheduling using Practice Management system for ordering of labs, diagnostic test orders and scheduling doctor’s visits, follow-up appointments and hospital procedures and surgeries as needed. Schedules appointments in order to optimize patient satisfaction, provider time and treatment room utilization. Confirms appointments and scans orders into Electronic …

Patient Satisfaction

(USA-OH-CINCINNATI) Scheduler - Oncology/Hematology | 11/19/2019

patient identification and maximum reimbursement for all billable clinical services rendered. The Scheduler may perform the following duties: Manages daily patient and physician scheduling using Practice Management system for ordering of labs, diagnostic test orders and scheduling doctor’s visits, follow-up appointments and hospital procedures and surgeries as needed. Schedules appointments in order to optimize patient satisfaction, provider time and treatment room utilization. Confirms appointments and scans orders into Electronic …

Imprivata

Duplication, fragmentation hamper interoperability efforts, impact patient safety | Healthcare IT News | 4/13/2020

… data. On the flip side, hospitals that did have EMPI support tools in place were able to achieve consistently correct patient identification at an overall average 93% of registrations and 85% of externally shared records … Verato, which has also partnered with healthcare IT security specialist Imprivata, is of the belief that alignment of disparate patient record platforms will help eliminate duplicate records, establish more accurate care histories and improve patient …

Verato

Duplication, fragmentation hamper interoperability efforts, impact patient safety | Healthcare IT News | 4/13/2020

patient identification at an overall average 93% of registrations and 85% of externally shared records among non-networked providers, according to the survey. THE LARGER TREND Duplicate records might also contain incomplete or outdated information and can affect the quality of care by forcing clinicians to make care decisions without important information such as recent lab results, allergies and current medications. Back in 2019, Verato and AdVault partnered on a …

Cerner

Rapid Patient Identification & Tracking Solution Developed for Virus Testing Provided By RMS Omega Technologies | PRWeb | 4/11/2020

Rapid Patient Identification & Tracking Solution Developed for Virus Testing Provided By RMS Omega Technologies Share Article Mobile Patient Identification and Tracking System Developed Amid Increase in COVID-19 Testing BALTIMORE (PRWEB) April 11, 2020 RMS … connect with all major hospital and EMR systems including EPIC, Cerner, and more. The mobile application, CaptureMax Healthcare, also provides essential analytical data using heat maps to track testing results and virus spread using the …

NextGate

Nebraska Health Information Initiative (NEHII) Taps NextGate for Statewide Patient Matching and Trusted Data Exchange | PR Newswire | 3/18/2020

PASADENA, Calif. NextGate , the global leader in healthcare enterprise identification, announced today that the Nebraska Health Information Initiative (NEHII) , a leading health information exchange (HIE) connecting over 70 percent of providers in Nebraska , has selected … increasingly critical for greater clinical, operational and financial performance. Inaccurate patient identification costs the U.S. healthcare system $6 billion annually and results in medical errors, data quality issues, administrative waste, and poor patient and provider …

Pfizer

COMBACTE-CARE Video: The Path to a Successful Recruitment - Combacte | 11/28/2019

… of the Spanish participation in the COMBACTE projects within the ATM-AVI program characterized by their complexity in terms of patient identification and site organizational aspects. We would like to outline how this team structure … no treatment options.The trial is carried out in collaboration with Pfizer. REJUVENATE’s primary objective is to test ATM-AVI as a treatment for hospitalized patients with a complicated intra-abdominal infection. Secondary objectives include assessment …

Optum360

Senior Patient Care Coordinator - Phoenix, AZ - UnitedHealth Group - Phoenix, AZ | 11/21/2019

… adapt, and we are vital part of their evolution. And that’s what fueled these exciting new opportunities. Who are we? Optum360 . We’re a dynamic new partnership formed by Dignity Health and Optum to combine our … The perfect candidate will facilitate the patient admission flow, including patient identification, accurate demographics, insurance authorization, notification and verification of insurance e - benefits in order to obtain accurate and prompt reimbursement. Additional duties include providing …

UnitedHealth Group

Senior Patient Care Coordinator - Phoenix, AZ - UnitedHealth Group - Phoenix, AZ | 11/21/2019

… new partnership formed by Dignity Health and Optum to combine our unique expertise. As part of the growing family of UnitedHealth Group , we’ll leverage our compassion, our talent, our resources and experience to bring financial … The perfect candidate will facilitate the patient admission flow, including patient identification, accurate demographics, insurance authorization, notification and verification of insurance e - benefits in order to obtain accurate and prompt reimbursement. Additional duties include providing …

UnitedHealth

Senior Patient Care Coordinator - Phoenix, AZ - UnitedHealth Group - Phoenix, AZ | 11/21/2019

… new partnership formed by Dignity Health and Optum to combine our unique expertise. As part of the growing family of UnitedHealth Group , we’ll leverage our compassion, our talent, our resources and experience to bring financial … The perfect candidate will facilitate the patient admission flow, including patient identification, accurate demographics, insurance authorization, notification and verification of insurance e - benefits in order to obtain accurate and prompt reimbursement. Additional duties include providing …

PTC Therapeutics

PTC Therapeutics Launches A No-Cost Testing Program to Drive AADC Deficiency Patient Identification | PR Newswire | 11/18/2019

SOUTH PLAINFIELD, N.J. PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced the launch of a no-cost testing program for aromatic L-amino acid decarboxylase (AADC) deficiency, a rare genetic condition. Children with AADC deficiency fail to thrive and commonly don’t reach developmental milestones that include being able to hold up their head, sit unassisted, and stand. 1 These patients also have muscular hypotonia, severe seizure-like episodes that include oculogyric …

Novartis

Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/8/2019

… That journey begins with identifying patients in our core therapeutic areas, Duchenne, the limb-girdle muscular dystrophies and MPS IIIA. Patient identification will be central to the commercial organization for the balance of 2019 and … Spinraza sites treating SMA. Based on the very strong results Novartis demonstrated with their recent launches of Zolgensma and understanding the label and the differences in patient population sizes between the two disease states, we …

Zebra Technologies

The global rfid in healthcare market size is expected to reach USD 10.65 Billion by 2025 - Yahoo Finance | Yahoo News | 7/1/2019

… pathology labs for efficient product tracking and better workflow management.The use of RFID technology enables better communication, adequate patient monitoring, patient identification, and patient tracking.This method aids in decreasing medication errors and increases safety.The rising … the RFID in healthcare market include LogiTag, CenTrak, SpaceCode, Impinj, Zebra Technologies Corporation, Biolog-id, Terso Solutions, Carinal Health, Mobile Aspects, Tagsys RFID, Pepperl+Fuchs, and metraTec GmbHAbout Reportlinker ReportLinker is an award-winning market …

Change Healthcare

Change Healthcare, CommonWell expand partnership for patient data interoperability | Becker’s Hospital Review | 6/26/2019

Change Healthcare, CommonWell expand partnership for patient data interoperability Jackie Drees - Print Email CommonWell Health Alliance is extending its contract with Nashville, Tenn.-based Change Healthcare to continue its access to the health technology company’s clinical interoperability services. Through the new six-year agreement, Change Healthcare will provide CommonWell patient identification and record locator services as well as document retrieval for patient treatment and access. CommonWell is a nonprofit trade …

Loxo Oncology

UPDATE – PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network | Globe Newswire | 6/25/2019

June 24, 2019 20:18 ET Source: PREMIA Holdings (HK) Ltd. HONG KONG, June 24, 2019 (GLOBE NEWSWIRE) – Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic partnership … China and Japan to create the fastest and most efficient patient identification and enrollment network.” About Loxo Oncology Inc. Loxo Oncology, a wholly-owned subsidiary of Eli Lilly and Company, is a biopharmaceutical company innovating …

GSK

Orchard Therapeutics plc (ORTX) CEO Mark Rothera on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/28/2019

… systematically to be a company driven by innovation with an intense focus on the patient. That helped us secure the GSK gene therapy portfolio last year and continues to make us a partner of choice … three areas. The market opportunity for our clinical stage programs, patient identification efforts, and market access preparations. First, let’s cover the market opportunity for our primary immune deficiencies and neurometabolic diseases clinical stage programs. Based …

Piper Jaffray

Caris Life Sciences to Present at 31st Annual Piper Jaffray Healthcare Conference | PR Newswire | 11/20/2019

… precision medicine, announced today that Brian J. Brille , Vice Chairman of the Company, will present at the 31 st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019 , at 12:50 p.m. Eastern Time at … traditional physician outreach model to a real-time approach where patient identification is completed at the lab and the physician is informed so that the patient can be enrolled days earlier, and remain in the …

Audentes Therapeutics, Inc. (BOLD) CEO Matt Patterson on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/11/2019

… Chang - Head, IR Matt Patterson - Chairman & CEO Natalie Holles - President & COO Conference Call Participants Dae Gon - SVB Leerink Chris Raymond - Piper Jaffray Anupam Rama - JPMorgan Steve Seedhouse - Raymond James Rajiv Prasad - William Blair Matthew Luchini … ASPIRO I’m pleased to share that as part of our patient identification efforts we were able to identify two additional patients who met the study criteria bringing the total planned enrollment to 10 patients or …

William Blair

Audentes Therapeutics, Inc. (BOLD) CEO Matt Patterson on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/11/2019

… Conference Call Participants Dae Gon - SVB Leerink Chris Raymond - Piper Jaffray Anupam Rama - JPMorgan Steve Seedhouse - Raymond James Rajiv Prasad - William Blair Matthew Luchini - BMO Capital Market Operator Good afternoon ladies and gentlemen and welcome … ASPIRO I’m pleased to share that as part of our patient identification efforts we were able to identify two additional patients who met the study criteria bringing the total planned enrollment to 10 patients or …

PTC Therapeutics’ (PTCT) CEO Stuart Peltz on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 10/30/2019

… Bernstein Joe Thome – Cowen and Company Peter Kim – Barclays Martin Auster – Credit Suisse Brian Abrahams – RBC Capital Markets Raju Prasad – William Blair Joel Beatty – Citi Operator Ladies and gentlemen, thank you for standing-by, and … mentioned that you’re tracking on the AADC program towards your patient identification goal. Just wondering if you could give us a little bit more granularity around that? Where are the patients being identified? Are coming …

Goldman Sachs

Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/8/2019

… Abrahams - RBC Capital Markets Debjit Chattopadhyay - H.C. Wainwright Tazeen Ahmad - Bank of America Merrill Lynch Gena Wang - Barclays Salveen Richter - Goldman Sachs Danielle Brill - Piper Jaffray Joel Beatty - Citi Ritu Baral - Cowen Brian Skorney - Robert … areas, Duchenne, the limb-girdle muscular dystrophies and MPS IIIA. Patient identification will be central to the commercial organization for the balance of 2019 and leading into 2020 and beyond. The genetic testing program decode …

Orchard Therapeutics plc (ORTX) CEO Mark Rothera on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/28/2019

… Officer and Chief Business Officer Conference Call Participants Anupam Rama - JPMorgan Ritu Baral - Cowen David Nierengarten - Wedbush Securities Graig Suvannavejh - Goldman Sachs Operator Good day, ladies and gentlemen, and welcome to the Orchard Therapeutics First … three areas. The market opportunity for our clinical stage programs, patient identification efforts, and market access preparations. First, let’s cover the market opportunity for our primary immune deficiencies and neurometabolic diseases clinical stage programs. Based …

JMP Securities

Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/8/2019

… Richter - Goldman Sachs Danielle Brill - Piper Jaffray Joel Beatty - Citi Ritu Baral - Cowen Brian Skorney - Robert W. Baird Liisa Bayko - JMP Securities Yun Zhong - Janney Tim Chiang - BTIG Operator Good day, ladies and gentlemen and … areas, Duchenne, the limb-girdle muscular dystrophies and MPS IIIA. Patient identification will be central to the commercial organization for the balance of 2019 and leading into 2020 and beyond. The genetic testing program decode …

Sarepta Therapeutics (SRPT) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/8/2019

… That journey begins with identifying patients in our core therapeutic areas: Duchenne, the limb-girdle muscular dystrophy and MPS IIIA. Patient identification will be central to the commercial organization for the balance of 2019 and … disease. Operator Our next question comes from Liisa Bayko of JMP Securities. Your line is open. Liisa Bayko – JMP Securities – Analyst Hi. Thanks for taking the question. Just a couple pertaining to the model. So …

RBC Capital Markets

Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/8/2019

… D and Chief Medical Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Whitney Ijem - Guggenheim Christopher Marai - Nomura Brian Abrahams - RBC Capital Markets Debjit Chattopadhyay - H.C. Wainwright Tazeen Ahmad - Bank of America Merrill Lynch Gena … areas, Duchenne, the limb-girdle muscular dystrophies and MPS IIIA. Patient identification will be central to the commercial organization for the balance of 2019 and leading into 2020 and beyond. The genetic testing program decode …

PTC Therapeutics’ (PTCT) CEO Stuart Peltz on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 10/30/2019

… Alethia Young – Cantor Vincent Chen – Bernstein Joe Thome – Cowen and Company Peter Kim – Barclays Martin Auster – Credit Suisse Brian Abrahams – RBC Capital Markets Raju Prasad – William Blair Joel Beatty – Citi Operator Ladies and gentlemen, thank … mentioned that you’re tracking on the AADC program towards your patient identification goal. Just wondering if you could give us a little bit more granularity around that? Where are the patients being identified? Are coming …

Guggenheim Securities

Regeneron Pharmaceuticals, Inc. (REGN) CEO Len Schleifer on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/5/2019

… Terence Flynn - Goldman Sachs Group Matthew Harrison - Morgan Stanley Yaron Werber - Cowen and Company Evan Seigerman - Crédit Suisse Yatin Suneja - Guggenheim Securities Matthew Holt - JPMorgan Chase & Co. Joshua Schimmer - Evercore ISI Operator Good morning, and … We expect growth to continue based on demographics, enhancements in patient identification and referrals. In addition, recent updates to the National Comprehensive Cancer Network, or NCCN guidelines, list Libtayo as the preferred single-agent systemic …

Blueprint Medicines Corporation (BPMC) CEO Jeff Albers on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/10/2019

… Officer Marion Dorsch - Chief Scientific Officer Conference Call Participants Terence Flynn - Goldman Sachs Joseph Thome - Cowen and Company Charles Zhu - Guggenheim Securities David Nierengarten - Wedbush Securities Andrew Berens - SVB Leerink Benedict Shim - Canaccord David Leibowitz … of the clinical data supporting our therapies, drive more effective patient identification and improve outcomes through increased testing and work with stakeholders across the healthcare system to facilitate patient access. We expect that this foundational …

Wedbush Securities

Orchard Therapeutics plc (ORTX) CEO Mark Rothera on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/28/2019

… Frank Thomas - Chief Financial Officer and Chief Business Officer Conference Call Participants Anupam Rama - JPMorgan Ritu Baral - Cowen David Nierengarten - Wedbush Securities Graig Suvannavejh - Goldman Sachs Operator Good day, ladies and gentlemen, and welcome to … three areas. The market opportunity for our clinical stage programs, patient identification efforts, and market access preparations. First, let’s cover the market opportunity for our primary immune deficiencies and neurometabolic diseases clinical stage programs. Based …

Catabasis Pharmaceuticals, Inc. (CATB) CEO Jill Milne on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/14/2019

… Donovan - Chief Medical Officer Andrew Nichols - Chief Scientific Officer Noah Clauser - Vice President of Finance Conference Call Participants Liana Moussatos - Wedbush Securities, Inc. Joel Beatty - Citigroup Hartaj Singh - Oppenheimer & Co., Inc. Operator Good day, ladies … patients have been identified and we’re looking to wrap up patient identification soon and complete enrollment. We are working with the sites so that the queue of identify patients can be scheduled for screening visits …

Leerink Partners

Audentes Therapeutics’ (BOLD) CEO Matt Patterson on Q3 2017 Results - Earnings Call Transcript | Seeking Alpha | 11/15/2017

… the animal data, on some of the neuromuscular functional tests first. Operator Our next question comes from Joseph Schwartz with Leerink Partners. Joseph Schwartz I was wondering if you could talk a little bit about … said before, and that’s true in all the rare diseases. Patient identification globally will be a robust effort for us continuing forward. But we’re encouraged by those numbers. And with regards to the delay and …

Kura Oncology’s (KURA) CEO Troy Wilson on Q3 2017 Results - Earnings Call Transcript | Seeking Alpha | 11/12/2017

… for questions. Question-and-Answer Session Operator Thank you, Sir. [Operator instructions] Our first question comes from Jonathan Chang of Leerink Partners. Your question please. Jonathan Chang Hi guys. Thanks for taking my questions and … the CXCL12 assay, that will be helpful for you for patient identification with your targeted approach. Can you give us a sense when is that will be available to help you start selecting those patients …

Texas Health Resources

(USA-TX-Dallas) In Room Dining Server | 12/4/2019

Job Information Texas Health Resources In Room Dining Server in Dallas , Texas Texas Health Dallas seeks to hire a In Room Dining Server, Full Time, to join the Food Nutrition Services Team! The address is … to confirm satisfaction with the patient. • Comply with hand hygiene, patient identification, and personal protective equipment (PPE) requirements. • Utilizes basic diet therapy training to assist patients in selecting correct menu items as needed. • Maintains food …

Genesis Healthcare

(USA-VT-Rutland) Nursing Unit Assistant (Casual/Per Diem) | 11/24/2019

Job Information Genesis Healthcare Nursing Unit Assistant (Casual/Per Diem) in Rutland , Vermont POSITION SUMMARY:The Unit Assistant works under the direction of the licensed nurse and assists the nursing staff in providing nonpatient care … and transports patients to rehab area; Notifies licensed nurse if patient identification is missing; Assist with the dining program as assigned. Assists with feeding patients in accordance with the Feeding Assistant Program once successfully completed …

Dignity Health

Senior Patient Care Coordinator - Phoenix, AZ - UnitedHealth Group - Phoenix, AZ | 11/21/2019

… evolution. And that’s what fueled these exciting new opportunities. Who are we? Optum360 . We’re a dynamic new partnership formed by Dignity Health and Optum to combine our unique expertise. As part of the growing family … The perfect candidate will facilitate the patient admission flow, including patient identification, accurate demographics, insurance authorization, notification and verification of insurance e - benefits in order to obtain accurate and prompt reimbursement. Additional duties include providing …

Sentara Healthcare

Sentara Healthcare integrates Imprivata biometric patient identification technology | 11/21/2019

Sentara Healthcare integrates Imprivata biometric patient identification technology Nov 21, 2019 Categories Biometrics News Healthcare Biometrics Over a century old Sentara Healthcare in Norfolk, Virginia, is now using biometric palm vein identity authentication to connect over 750,000 patients, in varying medical states, to their medical records in different electronic health record systems, writes Healthcare IT News. The institution was struggling with a growing number of patients and needed a solution …

The Christ Hospital, Cincinnati OH

(USA-OH-CINCINNATI) Scheduler - Oncology/Hematology | 11/19/2019

The Christ Hospital Health Network Scheduler - Oncology/Hematology in CINCINNATI , Ohio Title: Scheduler Shift: Full-Time, Days This position will be scheduled approximately 40 hours per week and work in an Oncology/Hematology practice at … for the purposes of ensuring quality patient care through proper patient identification and maximum reimbursement for all billable clinical services rendered. The Scheduler may perform the following duties: Manages daily patient and physician scheduling using …

Christ Hospital, Cincinnati OH

(USA-OH-CINCINNATI) Scheduler - Oncology/Hematology | 11/19/2019

The Christ Hospital Health Network Scheduler - Oncology/Hematology in CINCINNATI , Ohio Title: Scheduler Shift: Full-Time, Days This position will be scheduled approximately 40 hours per week and work in an Oncology/Hematology practice at … for the purposes of ensuring quality patient care through proper patient identification and maximum reimbursement for all billable clinical services rendered. The Scheduler may perform the following duties: Manages daily patient and physician scheduling using …

Kaiser Permanente

(USA-CA-Harbor City) Business Services Representative | 11/7/2019

Job Information Kaiser Permanente Business Services Representative in Harbor City , California Under indirect supervision, verifies insurance eligibility & benefits, interviews patient and/or their representative to obtain demographic & financial information, identify available payor sources & records information … Procedures, Principles of Responsibilities & applicable state, federal & local laws Verifies patient identification & insurance eligibility/benefits, Obtains required authorizations/pre-certifications & required billing information from all identified payor sources for Medical Office/ Hospital services rendered Interviews …

Northwell Health

(USA-NY-Tarrytown) Patient Access Representative (Eves/Nights) | 11/7/2019

Northwell Health Patient Access Representative (Eves/Nights) in Tarrytown , New York Req Number 002T8E Job Description Under the direction of the Patient Access Supervisor, the Patient Access Representative is responsible for ensuring seamless patient flow … into the hospital information system and assembles patient chart including patient identification bands and labels. Ensures patient identification band is placed on patient. Confirms patient’s insurance coverage eligibility and plan requirements utilizing the electronic verification …

St. Joseph Health

(USA-TX-Lubbock) Patient Access Rep | 10/31/2019

Job Information St. Joseph Health / Covenant Health Patient Access Rep in Lubbock , Texas We are looking for a Patient Access Representative in Patient Access Services Emergency Room Registration at Covenant Medical Center in Lubbock, Texas … rights. Facilitates the patient admission flow, including activities such as: patient identification, identification of accurate demographic information, and financial data retrieval of required signatures and documents. Enters the financial and admissions data into the hospital …

UPMC

UPMC Magee-Womens Hospital worker featured on ‘Good Morning America’ | TribLIVE.com | 10/15/2019

It doesn’t take Mary Ellen Kremer long to put a little sparkle into the day-to-day lives of patients at UPMC Magee-Womens Hospital in Oakland, and her simple act of kindness caught the attention of ABC’s “Good Morning America.” Kremer, a patient services representative at the hospital, was featured on the “Make Your Monday” segment this week for her colorful and crafty patient identification bracelets. After filling out …

University of Rochester

(USA-NY-Rochester) Outpatient Access Specialist - 218489 | 10/11/2019

University of Rochester Outpatient Access Specialist - 218489 in Rochester , New York Outpatient Access Specialist Full Time 40 hours Grade 007 Ambulatory Administration Responsibilities Position Summary: Performs functions associated with patient information processing for ambulatory care … Responsibilities: Reception: Greets patients to initiate positive ambulatory experience, requests patient identification, assures use of two identifiers to verify the correct patient, identifies healthcare provider to be seen, identifies referring provider and primary care physician …

Cigna

Thursday, October 31, 2019 | Kaiser Health News | 10/31/2019

… billion in fiscal year 2018. (Brady, 10/30) Modern Healthcare: Texas Awards Nearly $10 Billion In Medicaid Contracts Health insurers Anthem, Cigna Corp. and Molina Healthcare stand to lose millions in premium revenue after losing ground … Person. ProPublica investigates the sometime fatal consequences that come with patient identification errors, including one case where a family made the decision to take a patient off life-support only to realize after the autopsy …

Prognos Partners with Datavant, Using Health Data Ecosystem to Enhance AI Analytics for Customers | PR Newswire | 6/27/2019

patient identification for enhanced treatment decision-making, risk management and quality improvement. The company is supported by a $42M investment from Safeguard Scientifics, Inc., Merck Global Health Innovation Fund, Cigna, GIS Strategic Ventures, Hikma Ventures, Hermed Capital, and Maywic Select Investments. Learn more about Prognos at www.prognos.ai . About Datavant Datavant’s mission is to connect the world’s health data. Datavant works with data owners and users to ensure that data can …

Anupam Rama

Audentes Therapeutics, Inc. (BOLD) CEO Matt Patterson on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/11/2019

… IR Matt Patterson - Chairman & CEO Natalie Holles - President & COO Conference Call Participants Dae Gon - SVB Leerink Chris Raymond - Piper Jaffray Anupam Rama - JPMorgan Steve Seedhouse - Raymond James Rajiv Prasad - William Blair Matthew Luchini - BMO Capital … ASPIRO I’m pleased to share that as part of our patient identification efforts we were able to identify two additional patients who met the study criteria bringing the total planned enrollment to 10 patients or …

Orchard Therapeutics plc (ORTX) CEO Mark Rothera on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/28/2019

… Chief Executive Officer Bobby Gaspar - Chief Scientific Officer Frank Thomas - Chief Financial Officer and Chief Business Officer Conference Call Participants Anupam Rama - JPMorgan Ritu Baral - Cowen David Nierengarten - Wedbush Securities Graig Suvannavejh - Goldman Sachs Operator … three areas. The market opportunity for our clinical stage programs, patient identification efforts, and market access preparations. First, let’s cover the market opportunity for our primary immune deficiencies and neurometabolic diseases clinical stage programs. Based …

Andrew Chang

Audentes Therapeutics, Inc. (BOLD) CEO Matt Patterson on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/11/2019

Audentes Therapeutics, Inc. (NASDAQ: BOLD ) Q3 2019 Earnings 4:30 PM Andrew Chang - Head, IR Matt Patterson - Chairman & CEO Natalie Holles - President & COO Conference Call Participants Dae Gon - SVB Leerink Chris Raymond - Piper Jaffray Anupam Rama … ASPIRO I’m pleased to share that as part of our patient identification efforts we were able to identify two additional patients who met the study criteria bringing the total planned enrollment to 10 patients or …

Audentes Therapeutics, Inc. (BOLD) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/11/2019

… Audentes Therapeutics Third Quarter 2019 Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Andrew Chang Head of Investor Relations at Audentes. Please go ahead. Andrew Chang – Head of … ASPIRO I’m pleased to share that as part of our patient identification efforts we were able to identify two additional patients who met the study criteria bringing the total planned enrollment to 10 patients or …

Ritu Baral

Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/8/2019

… Ahmad - Bank of America Merrill Lynch Gena Wang - Barclays Salveen Richter - Goldman Sachs Danielle Brill - Piper Jaffray Joel Beatty - Citi Ritu Baral - Cowen Brian Skorney - Robert W. Baird Liisa Bayko - JMP Securities Yun Zhong - Janney … areas, Duchenne, the limb-girdle muscular dystrophies and MPS IIIA. Patient identification will be central to the commercial organization for the balance of 2019 and leading into 2020 and beyond. The genetic testing program decode …

Orchard Therapeutics plc (ORTX) CEO Mark Rothera on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/28/2019

… Bobby Gaspar - Chief Scientific Officer Frank Thomas - Chief Financial Officer and Chief Business Officer Conference Call Participants Anupam Rama - JPMorgan Ritu Baral - Cowen David Nierengarten - Wedbush Securities Graig Suvannavejh - Goldman Sachs Operator Good day, ladies … three areas. The market opportunity for our clinical stage programs, patient identification efforts, and market access preparations. First, let’s cover the market opportunity for our primary immune deficiencies and neurometabolic diseases clinical stage programs. Based …

Brian Abrahams

Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/8/2019

… President, R&D and Chief Medical Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Whitney Ijem - Guggenheim Christopher Marai - Nomura Brian Abrahams - RBC Capital Markets Debjit Chattopadhyay - H.C. Wainwright Tazeen Ahmad - Bank of America Merrill … areas, Duchenne, the limb-girdle muscular dystrophies and MPS IIIA. Patient identification will be central to the commercial organization for the balance of 2019 and leading into 2020 and beyond. The genetic testing program decode …

Sarepta Therapeutics (SRPT) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/8/2019

… That journey begins with identifying patients in our core therapeutic areas: Duchenne, the limb-girdle muscular dystrophy and MPS IIIA. Patient identification will be central to the commercial organization for the balance of 2019 and … therefore I haven’t answered. Operator Our next question comes from Brian Abrahams of RBC Capital. Your line is open. Brian Abrahams – RBC Capital Markets – Analyst Hi. Thanks very much for taking my questions. On micro …

Alethia Young

Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/8/2019

… Klapac - Senior Vice President, Gene Therapy Gilmore O’Neill - Executive Vice President, R&D and Chief Medical Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Whitney Ijem - Guggenheim Christopher Marai - Nomura Brian Abrahams - RBC Capital Markets … areas, Duchenne, the limb-girdle muscular dystrophies and MPS IIIA. Patient identification will be central to the commercial organization for the balance of 2019 and leading into 2020 and beyond. The genetic testing program decode …

PTC Therapeutics’ (PTCT) CEO Stuart Peltz on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 10/30/2019

… Alex Kane – Head-Investor Relations Stuart Peltz – Chief Executive Officer Marcio Souza – Chief Operating Officer Emily Hill – Chief Financial Officer Alethia Young – Cantor Vincent Chen – Bernstein Joe Thome – Cowen and Company Peter Kim – Barclays Martin … mentioned that you’re tracking on the AADC program towards your patient identification goal. Just wondering if you could give us a little bit more granularity around that? Where are the patients being identified? Are coming …

Marion McCourt

Regeneron Pharmaceuticals, Inc. (REGN) CEO Len Schleifer on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/5/2019

… Participants Justin Holko - VP, IR Len Schleifer - Co-Founder, President & CEO George Yancopoulos - Founding Scientist, President, Chief Scientific Officer & Director Marion McCourt - SVP & Head, Commercial Robert Landry - EVP, Finance & CFO Conference Call Participants Christopher Raymond … We expect growth to continue based on demographics, enhancements in patient identification and referrals. In addition, recent updates to the National Comprehensive Cancer Network, or NCCN guidelines, list Libtayo as the preferred single-agent systemic …

Regeneron Pharmaceuticals (REGN) Q1 2019 Earnings Call Transcript | Yahoo News | 5/8/2019

… are: Dr. Len Schleifer, founder, president, and chief executive officer; Dr. George Yancopoulos, founding scientist, president, and chief scientific officer; Marion McCourt, senior vice president and head of commercial; and Bob Landry, executive vice president … on Libtayo to grow based on demographics and enhancements of patient identification and physician referrals. Libtayo is the only FDA-approved treatment for advanced CSCC and the only anti-PD1 or PD-L1 with a …

Jitin Asnaani

CommonWell Grants Change Healthcare 6-Year Interoperability Contract | EHR Intelligence | 6/26/2019

… services. Source: Change Healthcare recently received a six-year contract from CommonWell Health Alliance to provide clinical interoperability services, including patient identification and record locator services. The healthcare company will also perform document retrieval for … to individuals and caregivers regardless of where care occurs,” said Jitin Asnaani, executive director of CommonWell Health Alliance. “Our partnership with Change Healthcare has enabled us to rapidly grow our national network — a critical component …

CommonWell enlists Change Healthcare for new interoperability work | Healthcare IT News | 6/26/2019

… Health Alliance has tapped Change Healthcare to bring information exchange technologies to members of the interoperability network. Change will provide patient identification and record locator tools, as well as document retrieval services. WHY IT MATTERS … to individuals and caregivers regardless of where care occurs,” said Jitin Asnaani, executive director of CommonWell Health Alliance, in a statement. “Our partnership with Change Healthcare has enabled us to rapidly grow our national network …

Mark Roth

Orchard Therapeutics plc (ORTX) CEO Mark Rothera on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/28/2019

… NASDAQ: ORTX ) Q1 2019 Earnings Conference Call May 28, 2019 8:00 AM ET Company Participants Renee Leck - Director, Investor Relations Mark Rothera - President, Chief Executive Officer Bobby Gaspar - Chief Scientific Officer Frank Thomas - Chief Financial … three areas. The market opportunity for our clinical stage programs, patient identification efforts, and market access preparations. First, let’s cover the market opportunity for our primary immune deficiencies and neurometabolic diseases clinical stage programs. Based …

Orchard Therapeutics plc (ORTX) Q1 2019 Earnings Call Transcript - Nasdaq.com | 5/28/2019

… obligation to update or revise any forward-looking statements. With that, I’ll turn the call over to President and CEO Mark Rothera. 10 stocks we like better than Orchard Rx Ltd When investing geniuses David … three areas: The market opportunity for our clinical-stage programs, patient identification efforts, and market access preparations. First, let’s cover the market opportunity for our primary immune deficiencies and neurometabolic diseases clinical-stage programs. Based …

Tom Gardner

Orchard Therapeutics plc (ORTX) Q1 2019 Earnings Call Transcript - Nasdaq.com | 5/28/2019

… to President and CEO Mark Rothera. 10 stocks we like better than Orchard Rx Ltd When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter … three areas: The market opportunity for our clinical-stage programs, patient identification efforts, and market access preparations. First, let’s cover the market opportunity for our primary immune deficiencies and neurometabolic diseases clinical-stage programs. Based …

Orchard Therapeutics plc (ORTX) Q1 2019 Earnings Call Transcript - Nasdaq.com | 5/28/2019

… to President and CEO Mark Rothera. 10 stocks we like better than Orchard Rx Ltd When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter … three areas: The market opportunity for our clinical-stage programs, patient identification efforts, and market access preparations. First, let’s cover the market opportunity for our primary immune deficiencies and neurometabolic diseases clinical-stage programs. Based …

David Nierengarten

Orchard Therapeutics plc (ORTX) CEO Mark Rothera on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/28/2019

… Scientific Officer Frank Thomas - Chief Financial Officer and Chief Business Officer Conference Call Participants Anupam Rama - JPMorgan Ritu Baral - Cowen David Nierengarten - Wedbush Securities Graig Suvannavejh - Goldman Sachs Operator Good day, ladies and gentlemen, and … three areas. The market opportunity for our clinical stage programs, patient identification efforts, and market access preparations. First, let’s cover the market opportunity for our primary immune deficiencies and neurometabolic diseases clinical stage programs. Based …

Blueprint Medicines Corporation (BPMC) CEO Jeff Albers on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/10/2019

… Dorsch - Chief Scientific Officer Conference Call Participants Terence Flynn - Goldman Sachs Joseph Thome - Cowen and Company Charles Zhu - Guggenheim Securities David Nierengarten - Wedbush Securities Andrew Berens - SVB Leerink Benedict Shim - Canaccord David Leibowitz - Morgan Stanley … of the clinical data supporting our therapies, drive more effective patient identification and improve outcomes through increased testing and work with stakeholders across the healthcare system to facilitate patient access. We expect that this foundational …